EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways

Bingyu Shen iD, Haoqing Zhang, Zhengjin Zhu, Zixi Ling, Fangyuan Zeng, Yazhou Wang, Jianguo Wang iD

Molecules · 2023

DOI: 10.3390/molecules28041873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Bingyu Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Pneumonia, Flavonoids. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Baicalin is an active ingredient extracted from the Chinese medicine Scutellaria and has many beneficial effects. Pulmonary interstitial and alveolar edema are common symptoms of an acute lung injury (ALI). We investigated the effects of baicalin on LPS-induced inflammation and the underlying mechanisms in mice and cells. The protein contents and mRNA expression of TNF-α, IL-1β, and IL-6 in RAW264.7 cells and mice were detected using ELISA and qRT-PCR. Baicalin significantly suppressed TNF-α, IL-1β, and IL-6 levels and expression, both in vitro and in vivo, compared with the LPS group. Baicalin inhibits the expression of TLR4 and MyD88, resulting in significant decreases in p-p65, p-p38, p-ERK, and p-JNK, as measured by the Western blotting of RAW264.7 cells. A baicalin treatment for 12 h resulted in a rapid increasing of the white blood cell number and significantly improved the pathological changes in the lung. We also found that the baicalin pretreatment for 12 h could decrease the MPO content and wet/dry (W/D) weight ratio, which indicates that baicalin can significantly reduce pulmonary edema. Furthermore, the baicalin pretreatment also resulted in the recovery of TGF-β protein levels and decreased iNOS. Baicalin inhibits ALI inflammation in mice and cells and is a potential candidate for the treatment of ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryPneumoniaFlavonoidsAnimalsMiceInflammationInterleukin-6LipopolysaccharidesLungNF-kappa BSignal TransductionTumor Necrosis Factor-alphaRAW 264.7 Cells

Stichwörter der Autor:innen

ALINF-κBbaicalincytokines

Substanzen

baicalinInterleukin-6LipopolysaccharidesNF-kappa BTumor Necrosis Factor-alphaFlavonoids

Autor:innen und Institutionen

  • College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China.

ORCID-Profile: Bingyu Shen, Jianguo Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shen, B., Zhang, H., Zhu, Z., Ling, Z., Zeng, F., Wang, Y., & Wang, J. (2023). Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways. Molecules. https://doi.org/10.3390/molecules28041873

Vancouver

Shen B, Zhang H, Zhu Z, Ling Z, Zeng F, Wang Y, et al. Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways. Molecules. 2023. doi:10.3390/molecules28041873

BibTeX
@article{Shen2023,
  author = {Shen, Bingyu and Zhang, Haoqing and Zhu, Zhengjin and Ling, Zixi and Zeng, Fangyuan and Wang, Yazhou and Wang, Jianguo},
  title = {Baicalin Relieves LPS-Induced Lung Inflammation via the NF-κB and MAPK Pathways},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28041873}
}
Kostenlos starten →